Masatsugu Hamaji, Keiji Yamanashi, Ryo Miyata, Takeshi Kawaguchi, Takeru Hyakutake, Michitaka Kimura, Takashi Tojo
We retrospectively reviewed patients undergoing lobectomy or segmentectomy between 2023 and 2025.
Segmentectomy is noninferior to lobectomy for early-stage non-small cell lung cancer (NSCLC), but its cost advantage remains unclear. We retrospectively reviewed patients undergoing lobectomy or segmentectomy between 2023 and 2025. High-cost disposable materials (≥ 15,000 JPY) were analyzed. Among 400 patients (lobectomy, n = 346; segmentectomy, n = 54), median total material costs were similar (473,370 vs. 480,420 JPY; ratio, 1.01; p = 0.87). Median stapler-related costs were also comparable (290,730 vs. 299,265 JPY; ratio, 1.03; p = 0.94). The costs were similar in video-assisted thoracoscopic surgery, whereas segmentectomy tended to be more expensive in robotic-assisted procedures (ratio, 1.11). Segmentectomy did not reduce the material costs compared with lobectomy, which may have implications for evaluating surgical value.